Novanta (NASDAQ:NOVT) Issues Q4 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its fourth quarter 2026 earnings guidance on Tuesday. The company provided EPS guidance of 0.910-0.960 for the period, compared to the consensus earnings per share estimate of 1.020. The company issued revenue guidance of $306.0 million-$312.0 million, compared to the consensus revenue estimate of $308.6 million. Novanta also updated its FY 2026 guidance to 3.660-3.710 EPS.

Novanta Stock Performance

NASDAQ NOVT opened at $123.31 on Thursday. The company has a quick ratio of 3.79, a current ratio of 1.18 and a debt-to-equity ratio of 0.48. Novanta has a 12-month low of $98.27 and a 12-month high of $176.38. The company has a market capitalization of $4.66 billion, a P/E ratio of 94.13 and a beta of 1.71. The firm has a 50-day moving average price of $141.40 and a two-hundred day moving average price of $142.45.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings data on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. The business had revenue of $305.01 million for the quarter, compared to analyst estimates of $301.02 million. Novanta had a return on equity of 10.23% and a net margin of 4.89%. Novanta’s quarterly revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.87 EPS. Analysts anticipate that Novanta will post 3.70 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Zacks Research downgraded shares of Novanta from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Robert W. Baird reduced their target price on shares of Novanta from $194.00 to $175.00 and set an “outperform” rating on the stock in a report on Thursday. Finally, Weiss Ratings cut shares of Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Novanta presently has a consensus rating of “Hold” and a consensus price target of $175.00.

About Novanta

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.